The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 3, 2006, Pages 1097-1105

  Longordo, Fabio ^a   Feligioni, Marco ^a   Chiaramonte, Greta ^b   Sbaffi, Pier Filippo ^b   Raiteri, Maurizio ^a   Pittaluga, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; DIZOCILPINE; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; METABOTROPIC RECEPTOR 1; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PERTUSSIS TOXIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; PRIORITY JOURNAL; UPREGULATION;

ADULT; AGED; ANIMALS; BRAIN; CELLS, CULTURED; FEMALE; GENE PRODUCTS, TAT; HIV-1; HUMANS; MALE; MIDDLE AGED; NEURONS; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; SYNAPTOSOMES; UP-REGULATION;

EID: 33646787850     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.099630     Document Type: Article

References (40)

1. Agnati LF, Ferre S, Lluis C, Franco R, and Fuxe K (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509-550.
2. Behnisch T, Francesconi W, and Sanna PP (2004) HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Res 1012:187-189.
3. Desce JM, Godeheu G, Galli T, Artaud F, Chèramy A, and Glowinski J (1992) L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and NMDA receptors. Neuroscience 47:335-339.
4. Diaz-Hernandez M, Sanchez-Nogueiro J, Pintor J, and Miras-Portugal MT (2004) Interaction between dinucleotide and nicotinic receptors in individual cholinergic terminals. J Pharmacol Exp Ther 311:954-967.
5. Diesing TS, Swindells S, Gelbard H, and Gendelman HE (2002) HIV-1-associated dementia: a basic science and clinical perspective. AIDS Read 12:358-368.
6. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, and Masliah E (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol 9:209-217.
7. Feligioni M, Raiteri L, Pattarini R, Grilli M, Bruzzone S, Cavazzani P, Raiteri M, and Pittaluga A (2003) The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms. J Neurosci 23:6810-6818.
8. Fink K, Bönisch H, and Göthert M (1990) Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur J Pharmacol 185:115-117.
9. Fink K, Schultheiss R, and Göthert M (1992) Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Br J Pharmacol 106:67-72.
10. Gelman BB, Soukup VM, Schuenke KW, Keherly MJ, Holzer C 3rd, Richey FJ, and Lahart CJ (2004) Acquired neuronal channelopathies in HIV-associated dementia. J Neuroimmunol 157:111-119.
11. Haughey NJ, Nath A, Mattson MP, Slevin JT, and Geiger JD (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 78:457-467.
12. Kaul M and Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 96:8212-8216.
13. Kew JNC, Richards JG, Mutel V, and Kemp JA (1998) Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct population of NMDA receptors in individual rat cortical neurons. J Neurosci 18:1935-1943.
14. Lawrence DM and Major EO (2002) HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect 4:301-308.
15. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, and Nath A (1995) Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37:373-380.
16. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, and Wiley CA (1992) Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32:321-329.
17. Nath A and Geiger JD (1998) Neurobiological aspects of HIV infections: neurotoxic mechanisms. Prog Neurobiol 54:19-33.
18. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, and Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186-194.
19. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DSK, Haughey N, and Geiger JD (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70:1475-1480.
20. Navia BA, Jordan BD, and Price RW (1986) The AIDS dementia complex: I. clinical features. Ann Neurol 19:517-524.
21. Nicoletti F, Bruno V, Copani A, Casabona G, and Knöpfel T (1996) Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 19:267-271.
22. Pattarini R, Pittaluga A, and Raiteri M (1998) The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience 87:147-157.
23. Pittaluga A, Feligioni M, Longordo F, Arvigo M, and Raiteri M (2005) Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. J Pharmacol Exp Ther 313:242-249.
24. Pittaluga A, Pattarini R, Feligioni M, and Raiteri M (2001) N-Methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH, and protein kinase C inhibition. J Neurochem 76:139-148.
25. Pittaluga A, Pattarini R, Severi P, and Raiteri M (1996) Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 10:463-468.
26. Pittaluga A and Raiteri M (1990) Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol 191:231-234.
27. Pittaluga A and Raiteri M (1992) N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release: I. location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther 260:232-237.
28. Pittaluga A and Raiteri M (1994) HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur J Neurosci 6:1743-1749.
29. Prendergast MA, Trent Rogers D, Mulholland PJ, Littleton JM, Wilkins LH Jr, Self RL, and Nath A (2002) Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Res 954:300-307.
30. Raiteri M, Garrone B, and Pittaluga A (1992) N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. J Pharmacol Exp Ther 260:238-242.
31. Raiteri L and Raiteri M (2000) Synaptosomes still viable after 25 years of superfusion. Neurochem Res 25:1265-1274.
32. Raiteri M, Sala R, Fassio A, Rossetto O, and Bonanno G (2000) Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J Neurochem 74:423-431.
33. Risso F, Grilli M, Parodi M, Bado M, Raiteri M, and Marchi M (2004) Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals. Neuropharmacology 47:65-71.
34. Salter MW and Kalia LV (2004) Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 5:317-328.
35. Savio T and Levi G (1993) Neurotoxicity of HIV coat protein gp120, NMDA receptors and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res 34:265-272.
36. 2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Brain Res 995:39-45.
37. Skeberdis VA, Lan JY, Opitz T, Zheng X, Bennett MVL, and Zukin RS (2001) mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40:856-865.
38. Song L, Nath A, Geiger JD, Moore A, and Hochman S (2003) Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol 9:399-403.
39. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, and Krammer PH (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (Lond) 375:497-500.
40. Yu XM, Askalan R, Keil GJ 2nd, and Salter MW (1997) NMDA channel regulation by channel-associated protein tyrosine kinase SRc. Science (Wash DC) 275:74-678.